Market closed
Envoy Medical Inc./$COCH
Envoy Medical shares are trading higher after the company announced a clinical trial milestone and plans to advance to the final stage.
23 hours ago·Lightyear AI
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
Ticker
$COCH
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
42
ISIN
US29415V1098
Website
COCH Metrics
BasicAdvanced
$36M
-
-$1.36
2.32
-
Price and volume
Market cap
$36M
Beta
2.32
52-week high
$1.91
52-week low
$1.21
Average daily volume
19K
Financial strength
Current ratio
1.094
Quick ratio
0.708
Long term debt to equity
-98.596
Total debt to equity
-99.195
Interest coverage (TTM)
-15.28%
Management effectiveness
Return on assets (TTM)
-129.07%
Return on equity (TTM)
123.42%
Valuation
Price to revenue (TTM)
156.15
Price to book
-1.5
Price to tangible book (TTM)
-1.5
Price to free cash flow (TTM)
-1.605
Growth
Revenue change (TTM)
-28.62%
Earnings per share change (TTM)
-23.31%
COCH News
AllArticlesVideos
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
Newsfile Corp·2 days ago
Envoy Medical Reports on First Quarter 2025 Results
Newsfile Corp·2 weeks ago
EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Envoy Medical Inc. stock?
Envoy Medical Inc. (COCH) has a market cap of $36M as of May 15, 2025.
What is the P/E ratio for Envoy Medical Inc. stock?
The price to earnings (P/E) ratio for Envoy Medical Inc. (COCH) stock is 0 as of May 15, 2025.
Does Envoy Medical Inc. stock pay dividends?
No, Envoy Medical Inc. (COCH) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next Envoy Medical Inc. dividend payment date?
Envoy Medical Inc. (COCH) stock does not pay dividends to its shareholders.
What is the beta indicator for Envoy Medical Inc.?
Envoy Medical Inc. (COCH) has a beta rating of 2.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.